Ashleigh Furlong

England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to only a small proportion of the patients who could benefit from it.

UK Prime Minister Keir Starmer is set to push for a new free trade deal with Gulf countries in a trip to the United Arab Emirates and Saudi Arabia next week.

Visit is prime minister's first to region since taking office Starmer will also discuss security concerns in the Middle East

Visit is prime minister's first to region since taking office UK said to be in final stages of negotiating free trade deal

A GSK Plc drug dramatically cut the risk of dying from an incurable blood cancer in a study, suggesting that the medicine withdrawn two years ago could return to market and become a blockbuster.

AlpInvest and Sixth Street are part of recapitalization deal Essential Pharma is looking for further acquisitions

Bavarian Nordic A/S agreed to a deal with the world’s largest vaccine manufacturer, the Serum Institute of India Pvt, to make the Danish biotech firm’s mpox shot.

Bavarian Nordic A/S partnered with the Serum Institute of India to produce its mpox vaccine. The Serum Institute will supply the Indian market and expand Bavarian's global manufacturing capacity through a profit-sharing agreement. This comes as mpox cases surge, predominantly in the Democratic Republic of Congo, with a mutated strain spreading globally.

A UK biotechnology startup is entering the crowded obesity drug market, armed with $411 million and a promising next-generation weight-loss pill.

A UK biotechnology startup is entering the crowded obesity drug market, armed with $US411 million ($664.2m) and a promising next-generation weight-loss pill.